Liz Helms, CEO of the Chronic Care Policy Alliance (CCPA), issued the following statement on Most Favored Nation pricing: “Most Favored Nation (MFN) pricing is not a patient-centered solution and will likely…
Webinar Recap: Drug Pricing Reform: What Patients Need to Know
On April 9, 2026, CCPA hosted “Drug Pricing Reform: What Patients Need to Know,” a webinar moderated by CCPA CEO Liz Helms. The panel featured Sue Peschin and Adina Lasser…
The Mass Compounded GLP-1 Market Is Harming Patients.
For people living with the chronic disease of obesity, GLP-1 medications have been life-changing. Research shows that sustained use reduces the risk of cardiovascular disease and other obesity-related complications while…
